69
Views
1
CrossRef citations to date
0
Altmetric
Original Research

The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis

, , , , , , & show all
Pages 143-149 | Published online: 08 Nov 2018

References

  • BraunJSieperJAnkylosing spondylitisLancet20073691379139017448825
  • RamiroSvan der HeijdeDvan TubergenAHigher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohortAnn Rheum Dis20147381455146124812292
  • El MaghraouiAExtra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implicationsEur J Intern Med201122655456022075279
  • NurmohamedMTvan der Horst-BruinsmaIMaksymowychWPCardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insightsCurr Rheumatol Rep201214541542122791397
  • PetersMJvan der Horst-BruinsmaIEDijkmansBANurmohamedMTCardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritisSemin Arthritis Rheum200434358559215609262
  • DikVKPetersMJDijkmansPAThe relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitisScand J Rheumatol2010391384120132069
  • KlingbergESveälvBGTängMSBech-HanssenOForsblad-D’EliaHBergfeldtLAortic Regurgitation Is Common in Ankylosing Spondylitis: Time for Routine Echocardiography Evaluation?Am J Med2015128111244125026052024
  • HeslingaSCvan DongenCJKoningsTCDiastolic left ventricular dysfunction in ankylosing spondylitis–a systematic review and meta-analysisSemin Arthritis Rheum2014441141924655534
  • Forsblad-D’EliaHWallbergHKlingbergECarlstenHBergfeldtLCardiac conduction system abnormalities in ankylosing spondylitis: a cross-sectional studyBMC Musculoskelet Disord20131423723937715
  • LangeUStapferGDittingTPathologic alterations of the heart and the kidney in patients with ankylosing spondylitisEur J Med Res2007121257358118024267
  • BulkleyBHRobertsWCAnkylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patientsCirculation1973485101410274751946
  • HaroonNNPatersonJMLiPInmanRDHaroonNPatients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality: A Population-Based StudyAnn Intern Med2015163640941626258401
  • SzaboSMLevyARRaoSRIncreased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based studyArthritis Rheum201163113294330421834064
  • PetersMJvan EijkICSmuldersYMSigns of accelerated preclinical atherosclerosis in patients with ankylosing spondylitisJ Rheumatol201037116116619955053
  • ZileMRBrutsaertDLNew concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatmentCirculation2002105121503150811914262
  • ChatterjeeKMassieBSystolic and diastolic heart failure: differences and similaritiesJ Card Fail200713756957617826648
  • van der LindenSValkenburgHACatsAEvaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteriaArthritis Rheum19842743613686231933
  • LangRMBadanoLPMor-AviVRecommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJ Am Soc Echocardiogr201528113925559473
  • NaguehSFAppletonCPGillebertTCRecommendations for the evaluation of left ventricular diastolic function by echocardiographyJ Am Soc Echocardiogr200922210713319187853
  • VahanianAAlfieriOAndreottiFAntunesMJBaron-EsquiviasGBaumgartnerHGuidelines on the management of valvular heart disease (version 2012)Eur Heart J2012332451249622922415
  • AslamFBandealiSJKhanNAAlamMDiastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic reviewArthritis Care Res2013654534543
  • ShangQTamLSYipGWHigh prevalence of subclinical left ventricular dysfunction in patients with psoriatic arthritisJ Rheumatol20113871363137021459943
  • LeveltEMahmodMPiechnikSKRelationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 DiabetesDiabetes2016651445226438611
  • SeferovićPMPaulusWJClinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypesEur Heart J201536271718172725888006
  • AljaroudiWAlraiesMCHalleyCImpact of progression of diastolic dysfunction on mortality in patients with normal ejection fractionCirculation2012125678278822261198
  • HalleyCMHoughtalingPLKhalilMKThomasJDJaberWAMortality rate in patients with diastolic dysfunction and normal systolic functionArch Intern Med2011171121082108721709107
  • PaulusWJTschöpeCA novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammationJ Am Coll Cardiol201362426327123684677
  • MassieBMCarsonPEMcmurrayJJIrbesartan in patients with heart failure and preserved ejection fractionN Engl J Med2008359232456246719001508
  • ChouCHLinMCPengCLA nationwide population-based retrospective cohort study: increased risk of acute coronary syndrome in patients with ankylosing spondylitisScand J Rheumatol201443213213624134400
  • PetersMJvan HalmVPVoskuylAEDoes rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective studyArthritis Rheum200961111571157919877093
  • HanCRobinsonDWHackettMVParamoreLCFraemanKHBalaMVCardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitisJ Rheumatol200633112167217216981296
  • WhiteWBCardiovascular effects of the selective cyclooxygenase-2 inhibitorsSubcell Biochem20074214515817612049
  • MaxwellLJZochlingJBoonenATNF-alpha inhibitors for ankylosing spondylitisCochrane Database Syst Rev20154CD005468
  • PutkoBNWangZLoJCirculating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiologyPLoS One201496e9949524923671
  • van EijkICPetersMJSernéEHMicrovascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockadeAnn Rheum Dis200968336236618390569
  • SariIOkanTAkarSImpaired endothelial function in patients with ankylosing spondylitisRheumatology200645328328616204374
  • EdelmannFGelbrichGDüngenHDExercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot studyJ Am Coll Cardiol201158171780179121996391
  • BrassardPLegaultSGarneauCBogatyPDumesnilJGPoirierPNormalization of diastolic dysfunction in type 2 diabetics after exercise trainingMed Sci Sports Exerc200739111896190117986895